Japan · Delayed Price · Currency is JPY Modalis Therapeutics Statistics
Total Valuation
TYO:4883 has a market cap or net worth of JPY 6.85 billion. The enterprise value is 3.58 billion.
| Market Cap | 6.85B |
| Enterprise Value | 3.58B |
Important Dates
The last earnings date was Thursday, August 7, 2025.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TYO:4883 has 76.93 million shares outstanding. The number of shares has increased by 93.23% in one year.
| Current Share Class | 76.93M |
| Shares Outstanding | 76.93M |
| Shares Change (YoY) | +93.23% |
| Shares Change (QoQ) | +4.74% |
| Owned by Insiders (%) | 10.34% |
| Owned by Institutions (%) | 4.04% |
| Float | 67.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.15 |
| P/TBV Ratio | 2.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.30 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.54 |
Financial Position
The company has a current ratio of 19.48
| Current Ratio | 19.48 |
| Quick Ratio | 19.19 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -704.17 |
Financial Efficiency
Return on equity (ROE) is -72.43% and return on invested capital (ROIC) is -65.56%.
| Return on Equity (ROE) | -72.43% |
| Return on Assets (ROA) | -60.63% |
| Return on Invested Capital (ROIC) | -65.56% |
| Return on Capital Employed (ROCE) | -72.14% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -111.24M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TYO:4883 has paid 1.03 million in taxes.
| Income Tax | 1.03M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.55% in the last 52 weeks. The beta is 0.13, so TYO:4883's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -48.55% |
| 50-Day Moving Average | 88.28 |
| 200-Day Moving Average | 95.55 |
| Relative Strength Index (RSI) | 50.72 |
| Average Volume (20 Days) | 1,446,535 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.34B |
| Pretax Income | -1.56B |
| Net Income | -1.56B |
| EBITDA | -2.34B |
| EBIT | -2.34B |
| Earnings Per Share (EPS) | -23.82 |
Balance Sheet
The company has 3.26 billion in cash and n/a in debt, giving a net cash position of 3.26 billion or 42.40 per share.
| Cash & Cash Equivalents | 3.26B |
| Total Debt | n/a |
| Net Cash | 3.26B |
| Net Cash Per Share | 42.40 |
| Equity (Book Value) | 3.19B |
| Book Value Per Share | 41.43 |
| Working Capital | 3.18B |
Cash Flow
In the last 12 months, operating cash flow was -1.41 billion and capital expenditures -583,000, giving a free cash flow of -1.41 billion.
| Operating Cash Flow | -1.41B |
| Capital Expenditures | -583,000 |
| Free Cash Flow | -1.41B |
| FCF Per Share | -18.35 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TYO:4883 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -93.23% |
| Shareholder Yield | n/a |
| Earnings Yield | -22.75% |
| FCF Yield | -20.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |